Cairo - Mubasher: A Saudi Company has acquired 25% of the DBK Pharmaceutical company shares, in a deal worth EGP 38.7 million (SAR 8.23 million).
Marae bin Mahfouz acquired the stake in the pharmaceutical company, which was previously listed on the Egyptian Exchange (EGX).
DBK is also in talks to sell another 20% of its shares.
